What are the latest figures on the aortic stenosis market’s size and projected CAGR?
The aortic stenosis market size has grown rapidly in recent years. It will grow from $7.88 billion in 2024 to $8.93 billion in 2025 at a compound annual growth rate (CAGR) of 13.3%. The growth in the historic period can be attributed to aging population, increased prevalence of risk factors, advancements in diagnostic technologies, growing awareness of heart diseases, improved healthcare infrastructure.
The aortic stenosis market size is expected to see rapid growth in the next few years. It will grow to $14.54 billion in 2029 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to rising adoption of minimally invasive procedures, expanding geriatric population, increasing healthcare expenditure, growth in healthcare access in emerging markets, advancements in aortic valve replacement technologies. Major trends in the forecast period include robotic-assisted surgery, 3d imaging and visualization, transcatheter aortic valve replacement (tavr) innovations, artificial intelligence in diagnostics, biodegradable stents.
Get Your Free Sample of The Global Aortic Stenosis Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21102&type=smp
Which Market drivers have played a significant role in driving the aortic stenosis market?
The increasing prevalence of heart diseases is expected to propel the growth of the aortic stenosis market going forward. Heart diseases refer to a range of conditions that affect the heart’s structure and function. These conditions can impact the heart’s ability to pump blood effectively, leading to complications. The common heart diseases are coronary artery disease (CAD), heart failure, arrhythmias, valvular heart disease, cardiomyopathy, and more. Aortic stenosis involves narrowing the aortic valve, which impedes blood flow from the left ventricle to the aorta. This increased resistance forces the heart to work harder, potentially leading to heart failure and other cardiovascular complications over time. Proper treatment of aortic stenosis, such as valve replacement or TAVI, helps improve heart function and reduces the risk of severe heart disease outcomes. For instance, in January 2025, according to the British Heart Foundation, a UK-based cardiovascular research charity, approximately 7.6 million people in the UK are living with heart and circulatory diseases, including around 4 million males and 3.6 million females. These conditions account for about 27% of all deaths in the UK, leading to over 170,000 fatalities annually, equivalent to 480 deaths per day. Therefore, the increasing prevalence of heart diseases is driving the growth of the aortic stenosis market.
What are the key segments within the aortic stenosis market?
The aortic stenosis market covered in this report is segmented –
1) By Type: Congenital Aortic Stenosis, Acquired Aortic Stenosis
2) By Treatment: Surgical Aortic Valve Replacement, Transcatheter Aortic Valve Replacement, Balloon Aortic Valvuloplasty
3) By Administration: Oral, Parenteral, Implants
4) By Distribution Channel: Offline, Online
5) By End User: Online Pharmacy, Retail Pharmacy, Hospital Pharmacy
Subsegments:
1) By Congenital Aortic Stenosis: Neonatal Aortic Stenosis, Infantile Aortic Stenosis, Juvenile Aortic Stenosis
2) By Acquired Aortic Stenosis: Age-Related Aortic Stenosis, Degenerative Aortic Stenosis, Rheumatic Aortic Stenosis
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/aortic-stenosis-global-market-report
Which key players are shaping the aortic stenosis market?
Major companies operating in the aortic stenosis market are AstraZeneca plc, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, Biotronik SE & Co. KG, LivaNova PLC, Meril Life Sciences Pvt Ltd., Shockwave Medical Inc., Venus Medtech, Egnite Inc., JenaValve Technology Inc, Peijia Medical, Micro Interventional Devices Inc, CryoLife Inc., Coroneo Meril Life Sciences Pvt Ltd, Thubrikar Aortic Valve Inc., Anteris Technologies Ltd., Cardiawave
Which transformative trends will shape the aortic stenosis market landscape?
Major companies operating in the aortic stenosis market are focusing on developing innovative aortic valve technologies, such as transcatheter aortic valve implantation (TAVI) systems, to improve patient outcomes, reduce procedural risks, and enhance the overall effectiveness of treatment for aortic. The transcatheter aortic valve implantation (TAVI) system is a minimally invasive medical device that can replace a diseased aortic valve without open-heart surgery. For instance, in January 2023, Abbott Laboratories, a US-based medical device company, received approval for Navitor, a latest-generation transcatheter aortic valve implantation (TAVI) system from the U.S. Food and Drug Administration (FDA). Navitor features the NaviSeal fabric cuff to reduce or eliminate paravalvular leaks. The system’s design, with leaflets within the native valve, aims to improve access to coronary arteries for future treatments of coronary artery disease.
How do regional factors impact the aortic stenosis market, and which region is the largest contributor?
North America was the largest region in the aortic stenosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aortic stenosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Aortic Stenosis Market Report 2025 Offer?
The aortic stenosis market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Aortic stenosis is a condition where the aortic valve in the heart becomes narrowed, restricting blood flow from the left ventricle to the aorta and the rest of the body. It is often caused by age-relate valve calcification, congenital valve defects, or rheumatic fever. Aortic stenosis can lead to serious complications such as heart failure, which can be treated with medication or surgical interventions such as valve replacement.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21102
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
